Global Glycobiology (Diagnostics and Therapeutics) Market Size, Status and Forecast 2019-2025

Global Glycobiology (Diagnostics and Therapeutics) Market Size, Status and Forecast 2019-2025

  • QYResearch
  • February 2019
  • Healthcare
  • 92 pages

Report Description

1
1
Glycobiology is the study of the structure, biosynthesis, and biology of saccharides that are widely distributed in nature. Glycobiology is the study of the structure, function and biology of carbohydrates, also called glycans. Glycans are present in every living organism. Glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology and basic research.
Glycans are diverse, complex molecules and their functions are determined by their unique structures. Effective enzymatic tools and analytical techniques are required to properly elucidate glycan structure, which can then be correlated to a specific function.
Glycosylation defines the adhesive properties of proteins and cells. The immune system largely functions via glycan-protein interactions, which highlights the importance of glycans in physiology, pathogen recognition, cancer and autoimmune diseases.
Glycan molecules modulate many other processes important for cell and tissue differentiation, metabolic and gene regulation, protein activity, protein clearance, transport and more.
In 2018, the global Glycobiology (Diagnostics and Therapeutics) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Glycobiology (Diagnostics and Therapeutics) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glycobiology (Diagnostics and Therapeutics) development in United States, Europe and China.

The key players covered in this study
Biomarin Pharmaceutical Inc.
Glycomimetics
Glycan Biosciences Llc
Glycosensors And Diagnostics Llc
Glycotest Inc.
...

Market segment by Type, the product can be split into
Diagnostics
Therapeutics

Market segment by Application, split into
Clinic
Hospital
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Glycobiology (Diagnostics and Therapeutics) status, future forecast, growth opportunity, key market and key players.
To present the Glycobiology (Diagnostics and Therapeutics) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Glycobiology (Diagnostics and Therapeutics) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Have query on this report?

Make an Enquiry
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
List of Tables and Figures
Table Glycobiology (Diagnostics and Therapeutics) Key Market Segments
Table Key Players Glycobiology (Diagnostics and Therapeutics) Covered
Table Global Glycobiology (Diagnostics and Therapeutics) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Glycobiology (Diagnostics and Therapeutics) Market Size Market Share by Type 2014-2025
Figure Diagnostics Figures

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074